CRMD
CorMedix Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.43
−0.47%Margins
Gross margin
82.8%
EBITDA margin
54.0%
EBIT margin
47.0%
Net margin
40.5%
FCF margin
54.5%
40.6%
Return on equity
20.7%
Return on assets
35.8%
Return on invested capital
0.54x
Asset turnover
$253.9M
Cash from operations
$3.29
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026